The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing may be under-reported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 is of clinical relevance and should be monitored closely.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678038 | PMC |
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.46.2001815 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!